Increased lipopolysaccharides lead to chronic inflammation, and treatment with adiponectin (ApN) has been able to provide therapeutic benefits in DMD through insulin-sensitising, fat-burning, anti-inflammatory, and anti-oxidative stress properties. Here, ADIPOQ is linked to Duchenne muscular dystrophy.